International Flavors & Fragrances (IFF) Consumer Analyst Group of New York Conference 2025 summary

Strategic overview and financial performance

• Achieved $11.5 billion in 2024 sales and $2.2 billion in EBITDA, with a 19.2% EBITDA margin, reflecting strong top and bottom-line performance.

• Business is highly diversified across Nourish, Health & Biosciences (H&B), Scent, and Pharma Solutions, with Pharma Solutions set to exit by Q2 2025.

• 2024 saw 6% top-line growth, 16% comparable EBITDA growth, and 210 basis points of margin expansion.

• Leverage improved from 4.4x to 3.8x, with a target to be below 3x net debt/EBITDA after Pharma Solutions divestiture and proceeds from recent divestitures.

• Capital allocation focuses on capacity expansion, digital transformation, maintaining a consistent dividend, and potential share buybacks once leverage targets are met.

Innovation, R&D, and business unit strategies

• Invests $671 million annually in R&D, representing 5.8% of sales, supporting 3,400 R&D employees, 8,000 patents, and 50+ research centers globally.

• H&B business leverages biotech capabilities, growing mid-single digits with a 30% EBITDA margin.

• Taste strategy targets increased penetration in private label and food service, with current private label share below 5%.

• Digital transformation and AI are being deployed to enhance efficiency and margin expansion.

• Business strategies for 2025 focus on independent business units, R&D leadership, digital acceleration, and cost structure transformation.

Biotech and Health & Biosciences focus

• Biotech capability built from Genencor, Danisco, DuPont, and IFF, with over 5,500 bioscience patents.

• Core technologies include enzymes, probiotics, and cultures, with a focus on discovery, scale, and application.

• R&D reinvestment in H&B is about 9% of sales, supporting a robust pipeline and global leadership.

• Recent innovations include TexStar enzymes for sugar-to-fiber conversion, next-gen anaerobic probiotics, and biodegradable polymers.

• Bioscience platform leverages unique capabilities across taste, scent, food ingredients, and health, with a robust pipeline of innovations.